世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 構造的心疾患向けインターベンショナルデバイス-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Interventional Devices for Structural Heart Disease- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 構造的心疾患用インターベンショナルデバイスの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年のCAGRは%になると予測されている。 構造的心... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー構造的心疾患用インターベンショナルデバイスの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年のCAGRは%になると予測されている。構造的心疾患とは、心臓組織や弁の異常によって引き起こされる心臓の物理的・生理的変化を指す。構造的心疾患の多くは先天性であり、一部の構造的心疾患は人生の後半に発症する。構造的心疾患の治療には、薬物療法、経カテーテル的インターベンション、開心術の3種類がある。構造的心疾患のインターベンション治療には、インターベンション機器が使用される。一般的なインターベンション機器には、先天性心疾患用閉塞器、心原性脳卒中用閉塞器、心臓弁製品がある。 構造的心疾患用インターベンショナルデバイスの北米市場は、2024年に100万ドルと評価され、2025年から2031年までの予測期間中に年平均成長率%で、2031年までに100万ドルに達する見込みです。 アジア太平洋地域の心臓構造疾患用インターベンショナルデバイス市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年には100万ドルに達する見込みです。 構造的心疾患用インターベンショナルデバイスのヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に年平均成長率%で、2031年までに100万ドルに達する見込みです。 構造的心疾患用インターベンショナルデバイスの世界の主要企業には、エドワーズライフサイエンス、ボストン・サイエンティフィック・コーポレーション、メドトロニック、アボット、リバノバ、クライオライフ、ブライレバイオメディカ、バイオメリックス、LLC、ニューメド社、アトリキュア社などが含まれる。2024年には、世界の大手5社が売上高で約 %のシェアを占めている。 本レポートは、構造的心疾患用インターベンショナルデバイスの世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 構造的心臓疾患用インターベンショナルデバイスの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データおよび予測データと合わせて、販売台数（Kユニット）および販売収益（百万ドル）で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、構造的心疾患用介入機器に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 エドワーズライフサイエンス ボストン・サイエンティフィック メドトロニック アボット リバノバ クライオライフ ブライユバイオメディカ バイオメリックスLLC ニューメッド社 アトリキュア社 コメッドB.V. 深圳サルブリス製薬有限公司 ライフテック・サイエンティフィック・コーポレーション 上海プッシュ医療機器技術有限公司 マイクロポート・サイエンティフィック・コーポレーション サイエンテックメディカル スターウェイメディカルテクノロジー株式会社 金星医療技術（杭州）有限公司 APTメディカル 上海ハートケア医療技術有限公司 培家医療有限公司 上海羽生医療技術有限公司 タイプ別セグメント 弁膜症治療機器 心原性脳卒中治療機器 先天性心疾患用インターベンション治療機器 用途別セグメント 先天性心疾患 後天性心疾患 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートの対象範囲、世界の総市場規模（金額、数量、価格）を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：心臓構造疾患用インターベンショナルデバイスメーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第5章： 構造的心疾患用インターベンショナルデバイスの地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場スペース、市場規模を紹介しています。 第6章 構造的心疾患用インターベンショナルデバイスの国別売上高、収益。各国・地域別にタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Interventional Devices for Structural Heart Disease Product Introduction 1.2 Global Interventional Devices for Structural Heart Disease Market Size Forecast 1.2.1 Global Interventional Devices for Structural Heart Disease Sales Value (2020-2031) 1.2.2 Global Interventional Devices for Structural Heart Disease Sales Volume (2020-2031) 1.2.3 Global Interventional Devices for Structural Heart Disease Sales Price (2020-2031) 1.3 Interventional Devices for Structural Heart Disease Market Trends & Drivers 1.3.1 Interventional Devices for Structural Heart Disease Industry Trends 1.3.2 Interventional Devices for Structural Heart Disease Market Drivers & Opportunity 1.3.3 Interventional Devices for Structural Heart Disease Market Challenges 1.3.4 Interventional Devices for Structural Heart Disease Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Interventional Devices for Structural Heart Disease Players Revenue Ranking (2024) 2.2 Global Interventional Devices for Structural Heart Disease Revenue by Company (2020-2025) 2.3 Global Interventional Devices for Structural Heart Disease Players Sales Volume Ranking (2024) 2.4 Global Interventional Devices for Structural Heart Disease Sales Volume by Company Players (2020-2025) 2.5 Global Interventional Devices for Structural Heart Disease Average Price by Company (2020-2025) 2.6 Key Manufacturers Interventional Devices for Structural Heart Disease Manufacturing Base and Headquarters 2.7 Key Manufacturers Interventional Devices for Structural Heart Disease Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Interventional Devices for Structural Heart Disease 2.9 Interventional Devices for Structural Heart Disease Market Competitive Analysis 2.9.1 Interventional Devices for Structural Heart Disease Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Interventional Devices for Structural Heart Disease Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Devices for Structural Heart Disease as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Interventional Devices for Valvular Disease 3.1.2 Interventional Devices for Cardiogenic Stroke 3.1.3 Interventional Devices for Congenital Heart Disease 3.2 Global Interventional Devices for Structural Heart Disease Sales Value by Type 3.2.1 Global Interventional Devices for Structural Heart Disease Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Interventional Devices for Structural Heart Disease Sales Value, by Type (2020-2031) 3.2.3 Global Interventional Devices for Structural Heart Disease Sales Value, by Type (%) (2020-2031) 3.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Type 3.3.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Interventional Devices for Structural Heart Disease Sales Volume, by Type (2020-2031) 3.3.3 Global Interventional Devices for Structural Heart Disease Sales Volume, by Type (%) (2020-2031) 3.4 Global Interventional Devices for Structural Heart Disease Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Congenital Heart Disease 4.1.2 Acquired Heart Disease 4.2 Global Interventional Devices for Structural Heart Disease Sales Value by Application 4.2.1 Global Interventional Devices for Structural Heart Disease Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Interventional Devices for Structural Heart Disease Sales Value, by Application (2020-2031) 4.2.3 Global Interventional Devices for Structural Heart Disease Sales Value, by Application (%) (2020-2031) 4.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Application 4.3.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Interventional Devices for Structural Heart Disease Sales Volume, by Application (2020-2031) 4.3.3 Global Interventional Devices for Structural Heart Disease Sales Volume, by Application (%) (2020-2031) 4.4 Global Interventional Devices for Structural Heart Disease Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Interventional Devices for Structural Heart Disease Sales Value by Region 5.1.1 Global Interventional Devices for Structural Heart Disease Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Interventional Devices for Structural Heart Disease Sales Value by Region (2020-2025) 5.1.3 Global Interventional Devices for Structural Heart Disease Sales Value by Region (2026-2031) 5.1.4 Global Interventional Devices for Structural Heart Disease Sales Value by Region (%), (2020-2031) 5.2 Global Interventional Devices for Structural Heart Disease Sales Volume by Region 5.2.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (2020-2025) 5.2.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (2026-2031) 5.2.4 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (%), (2020-2031) 5.3 Global Interventional Devices for Structural Heart Disease Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.4.2 North America Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.5.2 Europe Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.6.2 Asia Pacific Interventional Devices for Structural Heart Disease Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.7.2 South America Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.8.2 Middle East & Africa Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value 6.2.1 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.2.2 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.3.2 United States Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.4.2 Europe Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.5.2 China Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.5.3 China Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.6.2 Japan Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.7.2 South Korea Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.8.2 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.9.2 India Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.9.3 India Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Edwards Lifesciences 7.1.1 Edwards Lifesciences Company Information 7.1.2 Edwards Lifesciences Introduction and Business Overview 7.1.3 Edwards Lifesciences Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Edwards Lifesciences Interventional Devices for Structural Heart Disease Product Offerings 7.1.5 Edwards Lifesciences Recent Development 7.2 Boston Scientific Corporation 7.2.1 Boston Scientific Corporation Company Information 7.2.2 Boston Scientific Corporation Introduction and Business Overview 7.2.3 Boston Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Boston Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.2.5 Boston Scientific Corporation Recent Development 7.3 Medtronic 7.3.1 Medtronic Company Information 7.3.2 Medtronic Introduction and Business Overview 7.3.3 Medtronic Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Medtronic Interventional Devices for Structural Heart Disease Product Offerings 7.3.5 Medtronic Recent Development 7.4 Abbott 7.4.1 Abbott Company Information 7.4.2 Abbott Introduction and Business Overview 7.4.3 Abbott Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Abbott Interventional Devices for Structural Heart Disease Product Offerings 7.4.5 Abbott Recent Development 7.5 Livanova 7.5.1 Livanova Company Information 7.5.2 Livanova Introduction and Business Overview 7.5.3 Livanova Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Livanova Interventional Devices for Structural Heart Disease Product Offerings 7.5.5 Livanova Recent Development 7.6 Cryolife 7.6.1 Cryolife Company Information 7.6.2 Cryolife Introduction and Business Overview 7.6.3 Cryolife Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Cryolife Interventional Devices for Structural Heart Disease Product Offerings 7.6.5 Cryolife Recent Development 7.7 Braile Biomedica 7.7.1 Braile Biomedica Company Information 7.7.2 Braile Biomedica Introduction and Business Overview 7.7.3 Braile Biomedica Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Braile Biomedica Interventional Devices for Structural Heart Disease Product Offerings 7.7.5 Braile Biomedica Recent Development 7.8 Biomerics, LLC 7.8.1 Biomerics, LLC Company Information 7.8.2 Biomerics, LLC Introduction and Business Overview 7.8.3 Biomerics, LLC Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Biomerics, LLC Interventional Devices for Structural Heart Disease Product Offerings 7.8.5 Biomerics, LLC Recent Development 7.9 NuMed Inc. 7.9.1 NuMed Inc. Company Information 7.9.2 NuMed Inc. Introduction and Business Overview 7.9.3 NuMed Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 NuMed Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.9.5 NuMed Inc. Recent Development 7.10 AtriCure, Inc. 7.10.1 AtriCure, Inc. Company Information 7.10.2 AtriCure, Inc. Introduction and Business Overview 7.10.3 AtriCure, Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 AtriCure, Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.10.5 AtriCure, Inc. Recent Development 7.11 Comed B.V. 7.11.1 Comed B.V. Company Information 7.11.2 Comed B.V. Introduction and Business Overview 7.11.3 Comed B.V. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Comed B.V. Interventional Devices for Structural Heart Disease Product Offerings 7.11.5 Comed B.V. Recent Development 7.12 Shenzhen Salubris Pharmaceuticals Co., Ltd 7.12.1 Shenzhen Salubris Pharmaceuticals Co., Ltd Company Information 7.12.2 Shenzhen Salubris Pharmaceuticals Co., Ltd Introduction and Business Overview 7.12.3 Shenzhen Salubris Pharmaceuticals Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Shenzhen Salubris Pharmaceuticals Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.12.5 Shenzhen Salubris Pharmaceuticals Co., Ltd Recent Development 7.13 LifeTech Scientific Corporation 7.13.1 LifeTech Scientific Corporation Company Information 7.13.2 LifeTech Scientific Corporation Introduction and Business Overview 7.13.3 LifeTech Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 LifeTech Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.13.5 LifeTech Scientific Corporation Recent Development 7.14 Shanghai Push Medical Device Technology Co.,LTD 7.14.1 Shanghai Push Medical Device Technology Co.,LTD Company Information 7.14.2 Shanghai Push Medical Device Technology Co.,LTD Introduction and Business Overview 7.14.3 Shanghai Push Medical Device Technology Co.,LTD Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Shanghai Push Medical Device Technology Co.,LTD Interventional Devices for Structural Heart Disease Product Offerings 7.14.5 Shanghai Push Medical Device Technology Co.,LTD Recent Development 7.15 MicroPort Scientific Corporation 7.15.1 MicroPort Scientific Corporation Company Information 7.15.2 MicroPort Scientific Corporation Introduction and Business Overview 7.15.3 MicroPort Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 MicroPort Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.15.5 MicroPort Scientific Corporation Recent Development 7.16 Scientech Medical 7.16.1 Scientech Medical Company Information 7.16.2 Scientech Medical Introduction and Business Overview 7.16.3 Scientech Medical Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Scientech Medical Interventional Devices for Structural Heart Disease Product Offerings 7.16.5 Scientech Medical Recent Development 7.17 Starway Medical Technology Inc 7.17.1 Starway Medical Technology Inc Company Information 7.17.2 Starway Medical Technology Inc Introduction and Business Overview 7.17.3 Starway Medical Technology Inc Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.17.4 Starway Medical Technology Inc Interventional Devices for Structural Heart Disease Product Offerings 7.17.5 Starway Medical Technology Inc Recent Development 7.18 Venus Medtech (Hangzhou) Inc. 7.18.1 Venus Medtech (Hangzhou) Inc. Company Information 7.18.2 Venus Medtech (Hangzhou) Inc. Introduction and Business Overview 7.18.3 Venus Medtech (Hangzhou) Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.18.4 Venus Medtech (Hangzhou) Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.18.5 Venus Medtech (Hangzhou) Inc. Recent Development 7.19 APT Medical Inc 7.19.1 APT Medical Inc Company Information 7.19.2 APT Medical Inc Introduction and Business Overview 7.19.3 APT Medical Inc Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.19.4 APT Medical Inc Interventional Devices for Structural Heart Disease Product Offerings 7.19.5 APT Medical Inc Recent Development 7.20 Shanghai HeartCare Medical Technology Co., Ltd 7.20.1 Shanghai HeartCare Medical Technology Co., Ltd Company Information 7.20.2 Shanghai HeartCare Medical Technology Co., Ltd Introduction and Business Overview 7.20.3 Shanghai HeartCare Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.20.4 Shanghai HeartCare Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.20.5 Shanghai HeartCare Medical Technology Co., Ltd Recent Development 7.21 Peijia Medical Limited 7.21.1 Peijia Medical Limited Company Information 7.21.2 Peijia Medical Limited Introduction and Business Overview 7.21.3 Peijia Medical Limited Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.21.4 Peijia Medical Limited Interventional Devices for Structural Heart Disease Product Offerings 7.21.5 Peijia Medical Limited Recent Development 7.22 Shanghai Hanyu Medical Technology Co., Ltd 7.22.1 Shanghai Hanyu Medical Technology Co., Ltd Company Information 7.22.2 Shanghai Hanyu Medical Technology Co., Ltd Introduction and Business Overview 7.22.3 Shanghai Hanyu Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.22.4 Shanghai Hanyu Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.22.5 Shanghai Hanyu Medical Technology Co., Ltd Recent Development 8 Industry Chain Analysis 8.1 Interventional Devices for Structural Heart Disease Industrial Chain 8.2 Interventional Devices for Structural Heart Disease Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Interventional Devices for Structural Heart Disease Sales Model 8.5.2 Sales Channel 8.5.3 Interventional Devices for Structural Heart Disease Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Interventional Devices for Structural Heart Disease was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Interventional Devices for Structural Heart Disease Product Introduction 1.2 Global Interventional Devices for Structural Heart Disease Market Size Forecast 1.2.1 Global Interventional Devices for Structural Heart Disease Sales Value (2020-2031) 1.2.2 Global Interventional Devices for Structural Heart Disease Sales Volume (2020-2031) 1.2.3 Global Interventional Devices for Structural Heart Disease Sales Price (2020-2031) 1.3 Interventional Devices for Structural Heart Disease Market Trends & Drivers 1.3.1 Interventional Devices for Structural Heart Disease Industry Trends 1.3.2 Interventional Devices for Structural Heart Disease Market Drivers & Opportunity 1.3.3 Interventional Devices for Structural Heart Disease Market Challenges 1.3.4 Interventional Devices for Structural Heart Disease Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Interventional Devices for Structural Heart Disease Players Revenue Ranking (2024) 2.2 Global Interventional Devices for Structural Heart Disease Revenue by Company (2020-2025) 2.3 Global Interventional Devices for Structural Heart Disease Players Sales Volume Ranking (2024) 2.4 Global Interventional Devices for Structural Heart Disease Sales Volume by Company Players (2020-2025) 2.5 Global Interventional Devices for Structural Heart Disease Average Price by Company (2020-2025) 2.6 Key Manufacturers Interventional Devices for Structural Heart Disease Manufacturing Base and Headquarters 2.7 Key Manufacturers Interventional Devices for Structural Heart Disease Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Interventional Devices for Structural Heart Disease 2.9 Interventional Devices for Structural Heart Disease Market Competitive Analysis 2.9.1 Interventional Devices for Structural Heart Disease Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Interventional Devices for Structural Heart Disease Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Devices for Structural Heart Disease as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Interventional Devices for Valvular Disease 3.1.2 Interventional Devices for Cardiogenic Stroke 3.1.3 Interventional Devices for Congenital Heart Disease 3.2 Global Interventional Devices for Structural Heart Disease Sales Value by Type 3.2.1 Global Interventional Devices for Structural Heart Disease Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Interventional Devices for Structural Heart Disease Sales Value, by Type (2020-2031) 3.2.3 Global Interventional Devices for Structural Heart Disease Sales Value, by Type (%) (2020-2031) 3.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Type 3.3.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Interventional Devices for Structural Heart Disease Sales Volume, by Type (2020-2031) 3.3.3 Global Interventional Devices for Structural Heart Disease Sales Volume, by Type (%) (2020-2031) 3.4 Global Interventional Devices for Structural Heart Disease Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Congenital Heart Disease 4.1.2 Acquired Heart Disease 4.2 Global Interventional Devices for Structural Heart Disease Sales Value by Application 4.2.1 Global Interventional Devices for Structural Heart Disease Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Interventional Devices for Structural Heart Disease Sales Value, by Application (2020-2031) 4.2.3 Global Interventional Devices for Structural Heart Disease Sales Value, by Application (%) (2020-2031) 4.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Application 4.3.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Interventional Devices for Structural Heart Disease Sales Volume, by Application (2020-2031) 4.3.3 Global Interventional Devices for Structural Heart Disease Sales Volume, by Application (%) (2020-2031) 4.4 Global Interventional Devices for Structural Heart Disease Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Interventional Devices for Structural Heart Disease Sales Value by Region 5.1.1 Global Interventional Devices for Structural Heart Disease Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Interventional Devices for Structural Heart Disease Sales Value by Region (2020-2025) 5.1.3 Global Interventional Devices for Structural Heart Disease Sales Value by Region (2026-2031) 5.1.4 Global Interventional Devices for Structural Heart Disease Sales Value by Region (%), (2020-2031) 5.2 Global Interventional Devices for Structural Heart Disease Sales Volume by Region 5.2.1 Global Interventional Devices for Structural Heart Disease Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (2020-2025) 5.2.3 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (2026-2031) 5.2.4 Global Interventional Devices for Structural Heart Disease Sales Volume by Region (%), (2020-2031) 5.3 Global Interventional Devices for Structural Heart Disease Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.4.2 North America Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.5.2 Europe Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.6.2 Asia Pacific Interventional Devices for Structural Heart Disease Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.7.2 South America Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 5.8.2 Middle East & Africa Interventional Devices for Structural Heart Disease Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value 6.2.1 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.2.2 Key Countries/Regions Interventional Devices for Structural Heart Disease Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.3.2 United States Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.4.2 Europe Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.5.2 China Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.5.3 China Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.6.2 Japan Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.7.2 South Korea Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.8.2 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Interventional Devices for Structural Heart Disease Sales Value, 2020-2031 6.9.2 India Interventional Devices for Structural Heart Disease Sales Value by Type (%), 2024 VS 2031 6.9.3 India Interventional Devices for Structural Heart Disease Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Edwards Lifesciences 7.1.1 Edwards Lifesciences Company Information 7.1.2 Edwards Lifesciences Introduction and Business Overview 7.1.3 Edwards Lifesciences Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Edwards Lifesciences Interventional Devices for Structural Heart Disease Product Offerings 7.1.5 Edwards Lifesciences Recent Development 7.2 Boston Scientific Corporation 7.2.1 Boston Scientific Corporation Company Information 7.2.2 Boston Scientific Corporation Introduction and Business Overview 7.2.3 Boston Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Boston Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.2.5 Boston Scientific Corporation Recent Development 7.3 Medtronic 7.3.1 Medtronic Company Information 7.3.2 Medtronic Introduction and Business Overview 7.3.3 Medtronic Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Medtronic Interventional Devices for Structural Heart Disease Product Offerings 7.3.5 Medtronic Recent Development 7.4 Abbott 7.4.1 Abbott Company Information 7.4.2 Abbott Introduction and Business Overview 7.4.3 Abbott Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Abbott Interventional Devices for Structural Heart Disease Product Offerings 7.4.5 Abbott Recent Development 7.5 Livanova 7.5.1 Livanova Company Information 7.5.2 Livanova Introduction and Business Overview 7.5.3 Livanova Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Livanova Interventional Devices for Structural Heart Disease Product Offerings 7.5.5 Livanova Recent Development 7.6 Cryolife 7.6.1 Cryolife Company Information 7.6.2 Cryolife Introduction and Business Overview 7.6.3 Cryolife Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Cryolife Interventional Devices for Structural Heart Disease Product Offerings 7.6.5 Cryolife Recent Development 7.7 Braile Biomedica 7.7.1 Braile Biomedica Company Information 7.7.2 Braile Biomedica Introduction and Business Overview 7.7.3 Braile Biomedica Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Braile Biomedica Interventional Devices for Structural Heart Disease Product Offerings 7.7.5 Braile Biomedica Recent Development 7.8 Biomerics, LLC 7.8.1 Biomerics, LLC Company Information 7.8.2 Biomerics, LLC Introduction and Business Overview 7.8.3 Biomerics, LLC Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Biomerics, LLC Interventional Devices for Structural Heart Disease Product Offerings 7.8.5 Biomerics, LLC Recent Development 7.9 NuMed Inc. 7.9.1 NuMed Inc. Company Information 7.9.2 NuMed Inc. Introduction and Business Overview 7.9.3 NuMed Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 NuMed Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.9.5 NuMed Inc. Recent Development 7.10 AtriCure, Inc. 7.10.1 AtriCure, Inc. Company Information 7.10.2 AtriCure, Inc. Introduction and Business Overview 7.10.3 AtriCure, Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 AtriCure, Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.10.5 AtriCure, Inc. Recent Development 7.11 Comed B.V. 7.11.1 Comed B.V. Company Information 7.11.2 Comed B.V. Introduction and Business Overview 7.11.3 Comed B.V. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Comed B.V. Interventional Devices for Structural Heart Disease Product Offerings 7.11.5 Comed B.V. Recent Development 7.12 Shenzhen Salubris Pharmaceuticals Co., Ltd 7.12.1 Shenzhen Salubris Pharmaceuticals Co., Ltd Company Information 7.12.2 Shenzhen Salubris Pharmaceuticals Co., Ltd Introduction and Business Overview 7.12.3 Shenzhen Salubris Pharmaceuticals Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Shenzhen Salubris Pharmaceuticals Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.12.5 Shenzhen Salubris Pharmaceuticals Co., Ltd Recent Development 7.13 LifeTech Scientific Corporation 7.13.1 LifeTech Scientific Corporation Company Information 7.13.2 LifeTech Scientific Corporation Introduction and Business Overview 7.13.3 LifeTech Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 LifeTech Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.13.5 LifeTech Scientific Corporation Recent Development 7.14 Shanghai Push Medical Device Technology Co.,LTD 7.14.1 Shanghai Push Medical Device Technology Co.,LTD Company Information 7.14.2 Shanghai Push Medical Device Technology Co.,LTD Introduction and Business Overview 7.14.3 Shanghai Push Medical Device Technology Co.,LTD Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Shanghai Push Medical Device Technology Co.,LTD Interventional Devices for Structural Heart Disease Product Offerings 7.14.5 Shanghai Push Medical Device Technology Co.,LTD Recent Development 7.15 MicroPort Scientific Corporation 7.15.1 MicroPort Scientific Corporation Company Information 7.15.2 MicroPort Scientific Corporation Introduction and Business Overview 7.15.3 MicroPort Scientific Corporation Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 MicroPort Scientific Corporation Interventional Devices for Structural Heart Disease Product Offerings 7.15.5 MicroPort Scientific Corporation Recent Development 7.16 Scientech Medical 7.16.1 Scientech Medical Company Information 7.16.2 Scientech Medical Introduction and Business Overview 7.16.3 Scientech Medical Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Scientech Medical Interventional Devices for Structural Heart Disease Product Offerings 7.16.5 Scientech Medical Recent Development 7.17 Starway Medical Technology Inc 7.17.1 Starway Medical Technology Inc Company Information 7.17.2 Starway Medical Technology Inc Introduction and Business Overview 7.17.3 Starway Medical Technology Inc Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.17.4 Starway Medical Technology Inc Interventional Devices for Structural Heart Disease Product Offerings 7.17.5 Starway Medical Technology Inc Recent Development 7.18 Venus Medtech (Hangzhou) Inc. 7.18.1 Venus Medtech (Hangzhou) Inc. Company Information 7.18.2 Venus Medtech (Hangzhou) Inc. Introduction and Business Overview 7.18.3 Venus Medtech (Hangzhou) Inc. Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.18.4 Venus Medtech (Hangzhou) Inc. Interventional Devices for Structural Heart Disease Product Offerings 7.18.5 Venus Medtech (Hangzhou) Inc. Recent Development 7.19 APT Medical Inc 7.19.1 APT Medical Inc Company Information 7.19.2 APT Medical Inc Introduction and Business Overview 7.19.3 APT Medical Inc Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.19.4 APT Medical Inc Interventional Devices for Structural Heart Disease Product Offerings 7.19.5 APT Medical Inc Recent Development 7.20 Shanghai HeartCare Medical Technology Co., Ltd 7.20.1 Shanghai HeartCare Medical Technology Co., Ltd Company Information 7.20.2 Shanghai HeartCare Medical Technology Co., Ltd Introduction and Business Overview 7.20.3 Shanghai HeartCare Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.20.4 Shanghai HeartCare Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.20.5 Shanghai HeartCare Medical Technology Co., Ltd Recent Development 7.21 Peijia Medical Limited 7.21.1 Peijia Medical Limited Company Information 7.21.2 Peijia Medical Limited Introduction and Business Overview 7.21.3 Peijia Medical Limited Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.21.4 Peijia Medical Limited Interventional Devices for Structural Heart Disease Product Offerings 7.21.5 Peijia Medical Limited Recent Development 7.22 Shanghai Hanyu Medical Technology Co., Ltd 7.22.1 Shanghai Hanyu Medical Technology Co., Ltd Company Information 7.22.2 Shanghai Hanyu Medical Technology Co., Ltd Introduction and Business Overview 7.22.3 Shanghai Hanyu Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Sales, Revenue, Price and Gross Margin (2020-2025) 7.22.4 Shanghai Hanyu Medical Technology Co., Ltd Interventional Devices for Structural Heart Disease Product Offerings 7.22.5 Shanghai Hanyu Medical Technology Co., Ltd Recent Development 8 Industry Chain Analysis 8.1 Interventional Devices for Structural Heart Disease Industrial Chain 8.2 Interventional Devices for Structural Heart Disease Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Interventional Devices for Structural Heart Disease Sales Model 8.5.2 Sales Channel 8.5.3 Interventional Devices for Structural Heart Disease Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の医療機器・消耗品分野での最新刊レポート
本レポートと同じKEY WORD（devices）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
